Advanced Enzyme Technologies Limited has informed the Exchange that Record date for the purpose of Final Dividend is 23-Jul-2025.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Advanced Enzyme Technologies met on May 13, 2025 and approved the audited financial results for FY25 along with several other decisions. A final dividend of Rs 1.20 per share (60% on face value of Rs 2) has been recommended for FY24-25, subject to shareholder approval at the 36th AGM on July 30, 2025; the record date for this final dividend is July 23, 2025. Additionally, an interim dividend of Rs 4 per share (200% on face value of Rs 2) has been declared for FY25-26, with a record date of May 17, 2025, to be paid by June 10, 2025. On a consolidated basis, FY25 revenue grew modestly to Rs 6,369.10 million (from Rs 6,238.68 million in FY24), while net profit dipped slightly to Rs 1,339.74 million (from Rs 1,369.51 million), giving EPS of Rs 11.72. The board also approved incorporating a new wholly-owned subsidiary in India and appointed M/s Shiv Hari Jalan & Co. as secretarial auditors for five years. The statutory auditor MSKA & Associates issued an unmodified opinion on the results.
Shareholders stand to receive a combined Rs 5.20 per share in dividends (Rs 4 interim + Rs 1.20 final), which is a positive signal. However, the marginal revenue growth and slight decline in net profit may limit any major upside in the stock. The new subsidiary formation hints at future expansion plans worth monitoring.